| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.49.4.755 |
| P698 | PubMed publication ID | 4361711 |
| P2093 | author name string | Cohn JN | |
| Limas CJ | |||
| Guiha NH | |||
| Lekagul O | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 754-760 | |
| P577 | publication date | 1974-04-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain. | |
| P478 | volume | 49 |
| Q73531715 | Are myocardial functional abnormalities biventricular in nonalcoholic cirrhotics with or without ascites? |
| Q72595321 | Cardiac Function Assessed by Gated Heart Pool Studies in an Alcohol Clinic Population: A Preliminary Study |
| Q38746072 | Cardiac abnormalities in liver cirrhosis |
| Q42490724 | Cardiac excitation-contraction coupling in the portal hypertensive rat. |
| Q71261384 | Cardiac function in alcoholics with cirrhosis: absence of overt cardiomyopathy--myth or fact? |
| Q38626316 | Cardiac imaging in patients with chronic liver disease. |
| Q71603519 | Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related |
| Q71846415 | Cardiac plasma membrane physical properties and β-adrenergic receptor function are unaltered in portal-hypertensive rats |
| Q42704576 | Cardiopulmonary complications in chronic liver disease |
| Q37771146 | Cardiovascular changes in cirrhosis: pathogenesis and clinical implications |
| Q27010592 | Cardiovascular dysfunction in patients with liver cirrhosis |
| Q70156198 | Cardiovascular effects of alcohol |
| Q26778048 | Cirrhotic cardiomyopathy |
| Q59214654 | Cirrhotic cardiomyopathy |
| Q84383044 | Cirrhotic cardiomyopathy |
| Q93140565 | Cirrhotic cardiomyopathy |
| Q38268611 | Cirrhotic cardiomyopathy: a cardiologist's perspective |
| Q38161771 | Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. |
| Q38249191 | Cirrhotic cardiomyopathy: review of pathophysiology and treatment |
| Q68477905 | Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats |
| Q40148158 | Disturbed volume homeostasis in patients with cirrhosis of the liver |
| Q38133308 | Does cirrhotic cardiomyopathy exist? 50 years of uncertainty |
| Q73287228 | Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy |
| Q68725829 | Hepatocirculatory failure: diverse pathogeneses deserve diverse therapies |
| Q41047621 | Hepatorenal syndrome: a disease mediated by the intrarenal action of renin |
| Q26769598 | Left ventricular function assessment in cirrhosis: Current methods and future directions. |
| Q71732697 | Left ventricular function in liver cirrhosis |
| Q54676555 | Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis. |
| Q54033697 | Left ventricular volumes in liver cirrhosis. |
| Q48407843 | N-Terminal pro-B-Type Natriuretic Peptide Levels are Linked with Modified Child-Pugh Classification in Patients with Nonalcoholic Cirrhosis [NT-ProBNP and Liver Cirrhosis]. |
| Q37040910 | N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients |
| Q38709565 | Pathophysiology and epidemiology of portal hypertension |
| Q67441705 | Preclinical cardiomyopathy in chronic alcoholics: A sex difference |
| Q89976306 | Relationship between Heart Disease and Liver Disease: A Two-Way Street |
| Q71958800 | Relationship between cardiomyopathy and liver disease in chronic alcoholism |
| Q55060952 | Renal and cardiovascular dysfunction in liver disease. |
| Q71017523 | Renal sodium retention in liver disease |
| Q42470667 | The role of lipophilic bile acids in the development of cirrhotic cardiomyopathy |
| Q36495176 | Therapy insight: Cirrhotic cardiomyopathy |
Search more.